Evidence map›Paper›PMID 32897534›Full record

Observational studyJournal of endocrinological investigation2021

Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study.

A Jabbar, L Ingoe, H Thomas, P Carey, S Junejo, C Addison, J Vernazza, D Austin, J P Greenwood, A Zaman and 1 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of endocrinological investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

A JabbarTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.
L IngoeDepartment of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK.
H ThomasDepartment of Cardiology, Northumbria Healthcare NHS Foundation Trust, Cramlington, UK.
P CareyDepartment of Endocrinology and Cardiology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
S JunejoDepartment of Endocrinology and Cardiology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
C AddisonDepartment of Biochemistry, South of Tyne Pathology Centre, Gateshead Health NHS Foundation Trust, Gateshead, UK.
J VernazzaDepartment of Biochemistry, South of Tyne Pathology Centre, Gateshead Health NHS Foundation Trust, Gateshead, UK.
D AustinDepartment of Cardiology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
J P GreenwoodLeeds University and Leeds Teaching Hospitals NHS Trust, Leeds, UK.
A ZamanDepartment of Cardiology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
S RazviTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK. salman.razvi@ncl.ac.uk.ORCID http://orcid.org/0000-0002-9047-1556
Gateshead Health NHS Foundation Trust · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBSouth Tyneside and Sunderland NHS Foundation Trust · GBLeeds Teaching Hospitals NHS Trust · GBNorthumbria Healthcare NHS Foundation Trust · GBSouth Tees Hospitals NHS Foundation Trust · GB

Funding

Department of Health CDF-2012-05-231National Institute for Health Research CDF-2012-05-231
6 · The paper itself

Abstract

purposeThyroid dysfunction in patients with cardiac disease is associated with worse outcomes. This study aimed to evaluate the prevalence and analyse predictors and outcomes of thyroid dysfunction in patients presenting with an acute myocardial infarction (AMI).

methodsA prospective multicentre observational study of patients recruited from six acute hospitals within the North of England. Consecutive patients without previous thyroid disease presenting with both ST-elevation AMI (STEMI) and non-ST-elevation AMI (NSTEMI) were recruited to the Thyroxine in Acute Myocardial Infarction 1 (ThyrAMI-1) cohort study between December 2014 and 2016. Thyroid profile, standard biochemistry measurements and demographic information were obtained within 12 h of admission to hospital. Multivariable logistic regression analyses were performed to assess the predictors of thyroid dysfunction and Cox proportional hazards analyses were utilised to compare all-cause mortality by categories of thyroid dysfunction up to June 2019.

resultsOf the 1802 participants analysed, 1440 (79.9%) were euthyroid, 312 (17.3%) had subclinical hypothyroidism (SCH), 22 (1.2%) had subclinical hyperthyroidism (SHyper) and 25 (1.3%) had low T3 syndrome (LT3S). Predictors for SCH were increasing age, female sex, higher thyroid peroxidase antibody (TPOAb) levels, higher serum creatinine levels and early morning sampling time (between 00:01-06:00 h). The predictors of SHyper were lower body mass index and afternoon sampling time (between 12:01 and 18:00 h). Predictors of LT3S were increasing age, higher creatinine levels and presence of previous ischaemic heart disease. Compared to the euthyroid group, patients with LT3S had higher all-cause mortality; adjusted hazard ratio (95% CI) of 2.02 (1.03-3.95), p = 0.04, whereas those with SCH and SHyper did not exhibit significantly increased mortality; adjusted hazard ratios (95% CI) of 1.05 (0.74-1.49), p = 0.79 and 0.27 (0.04-1.95), p = 0.19, respectively.

conclusionsThyroid dysfunction is common in AMI patients on admission to hospital and our data provide an understanding regarding which factors might influence thyroid dysfunction in these patients. Furthermore, the negative association between LT3S and increased mortality post-AMI has once again been highlighted by this study. More research is required to assess if treatment of thyroid dysfunction improves clinical outcomes.

Indexed as

Euthyroid Sick SyndromesHyperthyroidismHypothyroidismMyocardial InfarctionAutoantibodiesCausalityCorrelation of DataCreatinineEnglandFemaleHumansMaleMiddle AgedMortalityPredictive Value of TestsPrevalenceanti-thyroid autoantibodiesAutoantibodiesCreatinineThyroxineAcute myocardial infarctionLow T3 syndromePrevalence and predictorsSubclinical hyperthyroidismSubclinical hypothyroidismThyroid dysfunction

Identifiers

PMID32897534
PMCPMC8124048
OpenAlexW3082540918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.